Sen. Sheldon Whitehouse Sells Off Shares of Kenvue Inc. (NYSE:KVUE)

Senator Sheldon Whitehouse (D-Rhode Island) recently sold shares of Kenvue Inc. NYSE: KVUE. In a filing disclosed on December 05th, the Senator disclosed that they had sold between $1,001 and $15,000 in Kenvue stock on November 18th.

Senator Sheldon Whitehouse also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of MetLife NYSE: MET on 11/19/2024.
• Purchased $15,001 - $50,000 in shares of Eli Lilly and Company NYSE: LLY on 10/30/2024.
• Sold $1,001 - $15,000 in shares of Starbucks NASDAQ: SBUX on 10/29/2024.
• Sold $1,001 - $15,000 in shares of Walt Disney NYSE: DIS on 10/29/2024.
• Sold $1,001 - $15,000 in shares of Honeywell International NASDAQ: HON on 10/29/2024.
• Sold $1,001 - $15,000 in shares of Mastercard NYSE: MA on 10/29/2024.
• Sold $1,001 - $15,000 in shares of Verizon Communications NYSE: VZ on 10/29/2024.
• Sold $100,001 - $250,000 in shares of Tesla NASDAQ: TSLA on 10/28/2024.
• Sold $15,001 - $50,000 in shares of Tesla NASDAQ: TSLA on 10/28/2024.
• Sold $15,001 - $50,000 in shares of Tesla NASDAQ: TSLA on 10/11/2024.

Kenvue Stock Performance

Shares of NYSE KVUE traded down $0.29 during trading hours on Friday, reaching $22.84. 9,708,660 shares of the stock were exchanged, compared to its average volume of 17,762,063. The stock's fifty day simple moving average is $22.97 and its 200 day simple moving average is $21.09. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $24.46. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. The firm has a market capitalization of $43.79 billion, a price-to-earnings ratio of 41.53, a P/E/G ratio of 2.13 and a beta of 1.36.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.28 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The firm had revenue of $3.90 billion for the quarter, compared to analyst estimates of $3.92 billion. During the same quarter last year, the company earned $0.31 EPS. The company's revenue was down .4% on a year-over-year basis. Sell-side analysts predict that Kenvue Inc. will post 1.07 EPS for the current year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, November 27th. Stockholders of record on Wednesday, November 13th were paid a dividend of $0.205 per share. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.59%. Kenvue's dividend payout ratio (DPR) is currently 149.09%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on KVUE. Jefferies Financial Group started coverage on Kenvue in a report on Tuesday, September 24th. They set a "buy" rating and a $27.00 price objective on the stock. Piper Sandler lifted their target price on Kenvue from $20.00 to $21.00 and gave the stock a "neutral" rating in a report on Monday, September 23rd. JPMorgan Chase & Co. lifted their target price on Kenvue from $24.00 to $25.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Royal Bank of Canada downgraded Kenvue from an "outperform" rating to a "sector perform" rating and set a $24.00 target price on the stock. in a report on Tuesday, September 24th. Finally, Bank of America lifted their target price on Kenvue from $24.00 to $27.00 and gave the stock a "buy" rating in a report on Tuesday, October 22nd. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $22.64.

Institutional Investors Weigh In On Kenvue

Institutional investors and hedge funds have recently made changes to their positions in the business. State Street Corp raised its stake in Kenvue by 16.8% during the 3rd quarter. State Street Corp now owns 127,213,940 shares of the company's stock worth $2,942,458,000 after buying an additional 18,283,473 shares during the period. Van ECK Associates Corp raised its stake in Kenvue by 110.9% during the 2nd quarter. Van ECK Associates Corp now owns 20,510,427 shares of the company's stock worth $372,880,000 after buying an additional 10,783,258 shares during the period. Bank of New York Mellon Corp raised its stake in Kenvue by 21.0% during the 2nd quarter. Bank of New York Mellon Corp now owns 43,444,085 shares of the company's stock worth $789,813,000 after buying an additional 7,546,362 shares during the period. Massachusetts Financial Services Co. MA raised its stake in Kenvue by 8.9% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 86,979,341 shares of the company's stock worth $2,011,832,000 after buying an additional 7,115,374 shares during the period. Finally, Holocene Advisors LP raised its stake in Kenvue by 75.5% during the 3rd quarter. Holocene Advisors LP now owns 13,886,454 shares of the company's stock worth $321,194,000 after buying an additional 5,975,392 shares during the period. Institutional investors own 97.64% of the company's stock.

About Senator Whitehouse

Sheldon Whitehouse (Democratic Party) is a member of the U.S. Senate from Rhode Island. He assumed office on January 3, 2007. His current term ends on January 3, 2025. Whitehouse (Democratic Party) is running for re-election to the U.S. Senate to represent Rhode Island. He declared candidacy for the 2024 election. Whitehouse previously served as the Rhode Island attorney general from 1999 to 2003. Before that, he was a United States attorney from 1994 to 1998. He was nominated to the position by President Bill Clinton (D). Whitehouse was a superdelegate to the 2016 Democratic National Convention from Rhode Island. He cast his vote for Hillary Clinton. As of a 2014 analysis of multiple outside rankings, Whitehouse is an average Democratic member of Congress, meaning he will vote with the Democratic Party on the majority of bills.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.